Has Michael Moore received payments from drug or device companies?

Yes. Drug and device makers reported $7,609 in general payments to Michael Moore across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Moore did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Moore come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Moore

Gynecology · Denver, CONPI 1275693608

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,180 of the $7,609 with a category attached, or 81.2%. Pfizer accounts for 82.9% of it on its own, with 8 other manufacturers making up the rest. 2023 is the largest year on record at $4,758, more than ten times the $97 reported in 2019.

$7,609in general payments, 2019–2025

Across 28 payments — averaging $271.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$6K
Sumitomo Pharma America, Inc.$644
AbbVie$269
Gynesonics, Inc.$225
Myovant Sciences Inc.$73
Exeltis, USA Inc.$34
plus $59 from 3 others

$654,612in research payments, 2019–2025

Across 300 payments — averaging $2182.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sumitomo Pharma America, Inc.$292K
AbbVie$235K
Bayer$95K
Myovant Sciences GmbH$24K
Myovant Sciences Inc.$6K
Gynesonics, Inc.$2K

What the payments were for

Speaking & faculty fees$6,18081%
Travel & lodging$2403%
Food & beverage$1,18916%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	3	$6,305
Sumitomo Pharma America, Inc.	4	$644
AbbVie	13	$269
Gynesonics, Inc.	2	$225
Myovant Sciences Inc.	1	$73
Exeltis, USA Inc.	2	$34
C. R. Bard, Inc. & Subsidiaries	1	$27
Bayer	1	$17
Pacira Pharmaceuticals Incorporated	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,609 in reported general payments places this provider in the 85th percentile of 31 gynecology providers in Colorado.

See all gynecology providers in Colorado →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol (Twice Weekly)Estradiol	17	$1,920
ProgesteroneProgesterone, Micronized	27	$1,124
Estradiol	22	$511
Levothyroxine Sodium	12	$8

Paid to pharmacies, not to this prescriber.

Other gynecology in Denver

Janet ShepherdDenver$288K
Mandi BemanDenver$29K
Arthur WaldbaumDenver$23K
Paula VasichkoDenver$5K
Kristinell KeilDenver$3K
Katherine DuganDenver$1K
Sybil DessieDenver$1K
Brenda KluherzDenver$890
Alexander ShapiroDenver$711
Gretchen BrunoDenver$32

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →